294 related articles for article (PubMed ID: 20924998)
21. Tuberous sclerosis complex.
Islam MP; Roach ES
Handb Clin Neurol; 2015; 132():97-109. PubMed ID: 26564073
[TBL] [Abstract][Full Text] [Related]
22. Stochastic model of Tsc1 lesions in mouse brain.
Prabhakar S; Goto J; Zhang X; Sena-Esteves M; Bronson R; Brockmann J; Gianni D; Wojtkiewicz GR; Chen JW; Stemmer-Rachamimov A; Kwiatkowski DJ; Breakefield XO
PLoS One; 2013; 8(5):e64224. PubMed ID: 23696872
[TBL] [Abstract][Full Text] [Related]
23. Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis.
Yeung RS; Katsetos CD; Klein-Szanto A
Am J Pathol; 1997 Nov; 151(5):1477-86. PubMed ID: 9358774
[TBL] [Abstract][Full Text] [Related]
24. The neurobiology of the tuberous sclerosis complex.
Marcotte L; Crino PB
Neuromolecular Med; 2006; 8(4):531-46. PubMed ID: 17028374
[TBL] [Abstract][Full Text] [Related]
25. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
Plank TL; Logginidou H; Klein-Szanto A; Henske EP
Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994
[TBL] [Abstract][Full Text] [Related]
26. Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.
Boer K; Troost D; Timmermans W; Gorter JA; Spliet WG; Nellist M; Jansen F; Aronica E
Neuroscience; 2008 Sep; 156(1):203-15. PubMed ID: 18706978
[TBL] [Abstract][Full Text] [Related]
27. Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors.
Henske EP; Wessner LL; Golden J; Scheithauer BW; Vortmeyer AO; Zhuang Z; Klein-Szanto AJ; Kwiatkowski DJ; Yeung RS
Am J Pathol; 1997 Dec; 151(6):1639-47. PubMed ID: 9403714
[TBL] [Abstract][Full Text] [Related]
28. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.
Talos DM; Kwiatkowski DJ; Cordero K; Black PM; Jensen FE
Ann Neurol; 2008 Apr; 63(4):454-65. PubMed ID: 18350576
[TBL] [Abstract][Full Text] [Related]
29. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.
Kotulska K; Borkowska J; Roszkowski M; Mandera M; Daszkiewicz P; Drabik K; Jurkiewicz E; Larysz-Brysz M; Nowak K; Grajkowska W; Domańska-Pakieła D; Jóźwiak S
Pediatr Neurol; 2014 Apr; 50(4):307-12. PubMed ID: 24507694
[TBL] [Abstract][Full Text] [Related]
30. Expression profiling in tuberous sclerosis complex (TSC) knockout mouse astrocytes to characterize human TSC brain pathology.
Ess KC; Uhlmann EJ; Li W; Li H; Declue JE; Crino PB; Gutmann DH
Glia; 2004 Apr; 46(1):28-40. PubMed ID: 14999811
[TBL] [Abstract][Full Text] [Related]
31. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.
Katz JS; Frankel H; Ma T; Zagzag D; Liechty B; Zeev BB; Tzadok M; Devinsky O; Weiner HL; Roth J
Childs Nerv Syst; 2017 Apr; 33(4):601-607. PubMed ID: 28074282
[TBL] [Abstract][Full Text] [Related]
32. Glioblastoma multiforme in a child with tuberous sclerosis complex.
Vignoli A; Lesma E; Alfano RM; Peron A; Scornavacca GF; Massimino M; Schiavello E; Ancona S; Cerati M; Bulfamante G; Gorio A; Canevini MP
Am J Med Genet A; 2015 Oct; 167A(10):2388-93. PubMed ID: 25946256
[TBL] [Abstract][Full Text] [Related]
33. Congenital segmental lymphedema in tuberous sclerosis complex with associated subependymal giant cell astrocytomas treated with Mammalian target of rapamycin inhibitors.
Prato G; Mancardi MM; Baglietto MG; Janis S; Vercellino N; Rossi A; Consales A; Raso A; Garrè ML
J Child Neurol; 2014 Sep; 29(9):NP54-7. PubMed ID: 24056156
[TBL] [Abstract][Full Text] [Related]
34. Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex.
Takahashi DK; Dinday MT; Barbaro NM; Baraban SC
Epilepsia; 2004 Dec; 45(12):1525-30. PubMed ID: 15571510
[TBL] [Abstract][Full Text] [Related]
35. Tuberous sclerosis complex neuropathology requires glutamate-cysteine ligase.
Malik AR; Liszewska E; Skalecka A; Urbanska M; Iyer AM; Swiech LJ; Perycz M; Parobczak K; Pietruszka P; Zarebska MM; Macias M; Kotulska K; Borkowska J; Grajkowska W; Tyburczy ME; Jozwiak S; Kwiatkowski DJ; Aronica E; Jaworski J
Acta Neuropathol Commun; 2015 Jul; 3():48. PubMed ID: 26220190
[TBL] [Abstract][Full Text] [Related]
36. [Tuberous sclerosis complex: A review].
Pfirmann P; Combe C; Rigothier C
Rev Med Interne; 2021 Oct; 42(10):714-721. PubMed ID: 33836894
[TBL] [Abstract][Full Text] [Related]
37. Tuberous sclerosis complex-associated CNS abnormalities depend on hyperactivation of mTORC1 and Akt.
Zordan P; Cominelli M; Cascino F; Tratta E; Poliani PL; Galli R
J Clin Invest; 2018 Apr; 128(4):1688-1706. PubMed ID: 29389670
[TBL] [Abstract][Full Text] [Related]
38. Minute amounts of hamartin wildtype rescue the emergence of tuber-like lesions in conditional Tsc1 ablated mice.
Robens BK; Grote A; Pitsch J; Schoch S; Cardoso C; Becker AJ
Neurobiol Dis; 2016 Nov; 95():134-44. PubMed ID: 27425891
[TBL] [Abstract][Full Text] [Related]
39. Missense mutations to the TSC1 gene cause tuberous sclerosis complex.
Nellist M; van den Heuvel D; Schluep D; Exalto C; Goedbloed M; Maat-Kievit A; van Essen T; van Spaendonck-Zwarts K; Jansen F; Helderman P; Bartalini G; Vierimaa O; Penttinen M; van den Ende J; van den Ouweland A; Halley D
Eur J Hum Genet; 2009 Mar; 17(3):319-28. PubMed ID: 18830229
[TBL] [Abstract][Full Text] [Related]
40. The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27.
Rosner M; Freilinger A; Hengstschläger M
Mutat Res; 2006 Sep; 613(1):10-6. PubMed ID: 16713332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
